RxDoctor Payments Data

Carol Leader, DO

Psychiatry · Lansing, MINPI 1659337301

Payments from drug & device makers

$433in general payments, 2019–2025

Across 25 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$100
  • Otsuka America Pharmaceutical, Inc.$63
  • Teva Pharmaceuticals USA, Inc.$59
  • Alkermes, Inc.$44
  • Johnson & Johnson$42
  • Indivior Inc.$36
  • plus $89 from 5 others

What the payments were for

  • Food & beverage$433100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$433 in reported general payments places this provider in the 60th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$25,961
Medicare patients
126
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate81$231,582
LybalviOlanzapine/Samidorphan Malate34$78,509
Abilify MaintenaAripiprazole26$72,484
AustedoDeutetrabenazine13$63,668
VraylarCariprazine Hcl33$46,841
Risperidone ErRisperidone Microspheres44$40,309
Lurasidone Hcl42$33,722
Aripiprazole227$16,769
Risperdal ConstaRisperidone Microspheres19$16,538
FanaptIloperidone12$11,167
Clozapine174$9,765
Divalproex Sodium201$9,105
Olanzapine OdtOlanzapine174$6,853
Paliperidone ErPaliperidone72$6,386
Olanzapine486$5,094

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$42$248,120100 claims
Alkermes, Inc.Lybalvi$44$78,50934 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$63$72,48426 claims
Teva Pharmaceuticals USA, Inc.Austedo$59$63,66813 claims
AbbVieVraylar$15$46,84133 claims
Vanda Pharmaceuticals Inc.Fanapt$15$11,16712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →